James Mond
Keine laufenden Positionen mehr
Profil
James Mond served as the Chief Medical Officer at Phase III Medical, Inc. before becoming the Executive VP, Chief Scientific & Medical Officer at ADMA Biologics, Inc. where he worked from 2012 to 2021.
Prior to that, he was the Chief Scientific Officer at Biosynexus, Inc. from 1999 to 2011.
He also worked as a Professor at the Uniformed Services University of the Health Sciences.
Dr. Mond holds a doctorate degree from the New York University School of Medicine.
Ehemalige bekannte Positionen von James Mond
| Unternehmen | Position | Ende |
|---|---|---|
| ADMA BIOLOGICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.06.2021 |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2011 |
| Phase III Medical, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
Ausbildung von James Mond
| New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADMA BIOLOGICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Phase III Medical, Inc. | Finance |
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |